Finally, a 20-mer peptide derived from the large extracellular loop (LEL) of KAI1 has been shown to have anti-angiogenic effects to block retinal neovascularization and the progression of breast cancer in vivo. This evidence concerns the gene CD82 and breast carcinoma.